This is a demo store. No orders will be fulfilled.

In Vitro Diagnostics (IVD)

  1. 08 Jun 2018  |  North America  |  Market Research

    US Cardiac Troponin Diagnostics Market, Forecast to 2021

    High Prevalence of Heart Disease Propels Market Growth

    Cardiac troponins help to diagnose nearly two-thirds of the patients in the diagnosis Acute Coronary Syndrome (ACS) who are missed out by Echocardiogram (ECG). ECG can detect only one-third of the patients with persistent ST-segment Elevation (STEMI), whereas cardiac troponins can distinguish patients without ST-segment elevation (NSTEACS; non-ST s...

    $4,950.00
  2. 25 May 2018  |  Europe  |  Market Research

    Western European Cardiac Troponin Diagnostics Market, Forecast to 2021

    Emerging Biomarkers Disrupt and Spur Growth in the Heart Disease Segment

    Cardiac troponins have now become the gold standard for early diagnosis of acute myocardial infarction, making them indispensable for clinical diagnosis of Acute Coronary Syndrome (ACS). Cardiac troponins play a key role in minimizing hospital stays and reducing admission rate which are the biggest contributors to overall healthcare expenditure. Fo...

    $3,000.00
  3. 16 Apr 2018  |  Asia Pacific  |  Market Research

    Analysis of the APAC Cardiac Troponin Diagnostics Market, Forecast to 2021

    Increasing Incidence Rates of Myocardial Infarction and Aging Population in APAC Drive the Troponin Diagnostics Market

    Cardiac troponins will continue to remain the gold standard for early diagnosis of acute myocardial infarction (AMI); however, the key challenge to address is the advent of a complementary biomarker to prevent repeat diagnosis. Multiplexing platforms should be harnessed for simultaneous testing of complementary biomarkers such as H-FABP, cardiac my...

    $3,000.00
  4. 04 Dec 2015  |  Asia Pacific  |  Market Research

    Vital Signs The Analyst's Perspective - October 2015 Issue

    This research service presents an overview and analysis of the Australian contract research organization (CRO) market. The research service provides market revenue forecasts by phase and therapeutic type and discusses major issues and challenges, unmet needs, and developing trends in the CRO market. The study covers the complete life cycle of the C...

    $450.00
  5. 30 Sep 2015  |  Asia Pacific  |  Market Research

    Vital Signs The Analyst's Perspective - September 2015 Issue

    This research service presents an overview and analysis of the contract research organization (CRO) market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The study discusses the key challenges, unmet needs, and emerging trends in the market and. It covers the complete life cycle of the CRO industry, starting from p...

    $450.00
  6. 21 Aug 2015  |  Asia Pacific  |  Market Research

    Vital Signs The Analyst's Perspective - July 2015 Issue

    This study presents an overview and analysis of the South Korean contract research organization (CRO) market. It provides market revenue forecasts by phase and therapeutic type and discusses major issues and challenges, unmet needs, and emerging trends. The study covers the complete life cycle of the CRO market, from preclinical trials to post-mark...

    $450.00
  7. 10 Jul 2015  |  Asia Pacific  |  Market Research

    Vital Signs - The Analyst's Perspective - June 2015 Issue

    The research service presents an overview and analysis of the China contract research organisation (CRO) market. It provides revenue forecasts by phase and therapeutic type and discusses the major issues and challenges, unmet needs, and emerging trends in the market. The study also covers the complete life cycle of the CRO industry, starting from p...

    $450.00
  8. 30 Jun 2015  |  Asia Pacific  |  Market Research

    Vital Signs - The Analyst's Perspective - May 2015 Issue

    This market insight presents an overview and analysis of the Singaporean CRO market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The research study discusses the major issues and challenges, unmet needs, and emerging trends in the market. The study covers the complete life cycle of the CRO industry, from preclini...

    $450.00
  9. 07 Apr 2015  |  North America  |  Market Research

    Vital Signs - The Analyst's Perspective - March 2015 Issue

    This market insight provides an analysis of the regulatory trends occurring in the US pharma/biotech industry for 2014. Included in this deliverable is an analysis of the new molecular entities (NME) approved by the US Food and Drug Administration in 2014 and predictions for 2015. Trends are showing that the US Food and Drug Administration is movin...

    $500.00